Status:
UNKNOWN
Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development
Lead Sponsor:
Jilin University
Conditions:
Breast Cancer Prevention
Eligibility:
FEMALE
18-80 years
Brief Summary
This study aims to prove whether antler disk extract can be put into clinical practice to prevent breast precancerous lesions from developing into cancer.
Detailed Description
Through estrogen receptor antagonists, tamoxifen can reduce the risk of breast high-risk disease progression to cancer, but only reduce the probability of some ER and PR positive tumors, which has no ...
Eligibility Criteria
Inclusion
- Women between the ages of 18 and 80
- Atypical hyperplasia or / and lobular carcinoma in situ confirmed by breast histology
- Women with breast cancer in first degree relatives
- Patients have better compliance with a series of research-related behaviors such as the upcoming comprehensive treatment and follow-up, and can understand and accept the research process of this study, and sign a written informed consent
Exclusion
- Hepatorenal dysfunction, cardiovascular and cerebrovascular diseases
- Patients not suitable for this study judged by researchers
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04440683
Start Date
June 1 2020
End Date
June 1 2025
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Hospital of Jilin University
Changchun, Jilin, China, 130021